The Union for International Cancer Control (UICC) and ISOPP issued a joint statement on July 8, 2025 in response to the findings reported in The Lancet Global Health, an article with Dr Benyam Muluneh, an ISOPP member, as an author, which revealed that approximately one in six anticancer medication samples collected from public hospitals and private pharmacies across multiple countries in sub-Saharan Africa failed to meet international pharmaceutical standards, with the active pharmaceutical ingredient levels varying from as low as 28% to as high as 120%.
Oncology pharmacy professionals stand at the frontline of medication safety. And ISOPP has committed to:
- Provide education to oncology pharmacists and technicians for outcome monitoring and supply-chain oversight.
- Partner with interested parties to develop quality-control protocols and standard operating procedures to strengthen the global supply chain.
- Facilitate knowledge-sharing across countries and institutions to rapidly disseminate lessons learned and best practices.
More information on this will follow in the next few weeks. Link to full statement here https://www.isopp.org/article/isopp-news/uicc-isopp-joint-statement